EP Patent

EP2570128A1 — Muscarinic acetylcholine receptor antagonists

Assigned to Glaxo Group Ltd · Expires 2013-03-20 · 13y expired

What this patent protects

Muscarinic Acetylcholine Receptor Antagonists of formula (I). These compounds are suitable for the treatment of muscarinic acetylcholine receptor mediated diseases.

USPTO Abstract

Muscarinic Acetylcholine Receptor Antagonists of formula (I). These compounds are suitable for the treatment of muscarinic acetylcholine receptor mediated diseases.

Drugs covered by this patent

Patent Metadata

Patent number
EP2570128A1
Jurisdiction
EP
Classification
—
Expires
2013-03-20
Drug substance claim
No
Drug product claim
No
Assignee
Glaxo Group Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.